GSK has set its sights on dominance of the market for hepatitis B virus (HBV) therapeutics, licensing an antisense oligonucleotide drug from Arrowhead Pharma and Johnson & Johnson that had been ...
Capital Environment Holdings Ltd is an investment holding company principally engaged in in provision of waste treatment technologies and services which specializes in technology development, design, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results